SEEBRI BREEZHALER 50 MCG — DIN 02394936
GLYCOPYRRONIUM (GLYCOPYRRONIUM BROMIDE) : 50 MCG · NOVARTIS PHARMACEUTICALS CANADA INC · CAPSULE · wholesale supply in Canada
Health Canada status: MARKETED
What is SEEBRI BREEZHALER?
SEEBRI BREEZHALER 50 MCG contains GLYCOPYRRONIUM (GLYCOPYRRONIUM BROMIDE) : 50 MCG. It is listed in the Health Canada Drug Product Database under DIN 02394936, held by NOVARTIS PHARMACEUTICALS CANADA INC, supplied as CAPSULE for INHALATION administration. Health Canada currently lists it as marketed, status dated 14-Jan-2013. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is SEEBRI BREEZHALER used for?
Long-term once-daily maintenance bronchodilator treatment in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. Not for acute relief.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 50 MCG |
|---|---|
| Dosage form | CAPSULE |
| Route | INHALATION |
| Pack configuration (monograph) | Cartons of 30 capsules (3 blister cards) with 1 inhaler; Cartons of 10 capsules (1 blister card) with 5 inhalers. |
| Storage | Store capsules in the blister to protect from moisture; remove immediately before use. (Specific temperature range not provided in text snippet). |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Glycopyrronium Bromide |
|---|---|
| ATC code | R03BB06 |
| AHFS class | 48:12.08 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02394936 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2394936 |
| Brand name | SEEBRI BREEZHALER |
| Generic / active ingredient | GLYCOPYRRONIUM (GLYCOPYRRONIUM BROMIDE) : 50 MCG |
| Market authorization holder | NOVARTIS PHARMACEUTICALS CANADA INC |
| Health Canada schedule | Prescription |
| ATC code | R03BB06 |
| ATC anatomical main group | R — Respiratory system |
| ATC therapeutic subgroup | R03BB |
| Current status | MARKETED |
| Status date | 14-Jan-2013 |
| Original market date | 2013-01-14 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Once-daily oral inhalation of the content of one 50 mcg capsule using the SEEBRI BREEZHALER inhaler. Capsules must not be swallowed. Administer at the same time each day.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity to glycopyrronium bromide or any ingredient in the formulation/container; severe hypersensitivity to milk proteins.
Warnings and precautions
Not for acute use/rescue therapy. Risk of paradoxical bronchospasm, worsening of narrow-angle glaucoma, and urinary retention. Caution in patients with cardiovascular disease.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
2 · Same class — other molecules in ATC R03BB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Ipratropium Bromide | AA-IPRAVENT · APO-IPRAVENT STERULES · ATROVENT · ATROVENT HFA · ATROVENT NASAL AEROSOL 20MCG/AEM · ATROVENT UDV 125MCG/ML · ATROVENT UDV SOL INH 250MCG/ML · DOM-IPRATROPIUM 125 MCG/ML · DOM-IPRATROPIUM 250 MCG/ML (1 ML) · DOM-IPRATROPIUM 250 MCG/ML (2 ML) · DOM-IPRATROPIUM 250 MCG/ML (20 ML) · JAMP IPRATROPIUM HFA · MYLAN-IPRATROPIUM SOLUTION · NOVO-IPRAMIDE - LIQ 0.25MG/ML · NU-IPRATROPIUM PLASTIC AMPULES 250 MCG/ML · PENTA-IPRATROPIUM BROMIDE · PHL-IPRATROPIUM · PHL-IPRATROPIUM - 1ML POLYNEB · PHL-IPRATROPIUM - 20ML · PHL-IPRATROPIUM - 2ML POLYNEB · PMS-IPRATROPIUM · RATIO-IPRATROPIUM INHALATION SOLUTION · RATIO-IPRATROPIUM UDV · TEVA-IPRATROPIUM STERINEBS | 30 | 8 | Yes |
| Tiotropium Bromide | APO-TIOTROPIUM · LUPIN-TIOTROPIUM · SPIRIVA · SPIRIVA RESPIMAT | 4 | 4 | Yes |
| Aclidinium Bromide | TUDORZA GENUAIR | 1 | 1 | Yes |
| Glycopyrronium Bromide | SEEBRI BREEZHALER | 1 | 1 | Yes |
| Umeclidinium Bromide | INCRUSE ELLIPTA | 1 | 1 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC R03B
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| R03BA | Beclometasone · Budesonide · Ciclesonide · Flunisolide · Fluticasone · Fluticasone Furoate · Mometasone · Triamcinolone | 66 | 33 |
| R03BC | Cromoglicic Acid · Nedocromil | 11 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.